Cargando…
Clinical outcome and toxicity evaluation of simultaneous integrated boost pelvic IMRT/VMAT at different dose levels combined with androgen deprivation therapy in prostate cancer patients
BACKGROUND: The role of dose escalation in patients receiving long-term androgen deprivation therapy (ADT) is still a controversial issue. The aim of the current study was to evaluate whether dose escalation for ≥76–80 Gy had any advantage in terms of biochemical disease-free survival (BDFS), distan...
Autores principales: | Daoud, Mohamed A, Aboelnaga, Engy M, Alashry, Mohamed S, Fathy, Salwa, Aletreby, Mostafa A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644603/ https://www.ncbi.nlm.nih.gov/pubmed/29066917 http://dx.doi.org/10.2147/OTT.S141224 |
Ejemplares similares
-
Dosimetric Comparison of the Simultaneous Integrated Boost in Whole-Breast Irradiation after Breast-Conserving Surgery: IMRT, IMRT plus an Electron Boost and VMAT
por: Wu, Sangang, et al.
Publicado: (2015) -
Dosimetric comparisons of VMAT, IMRT and 3DCRT for locally advanced rectal cancer with simultaneous integrated boost
por: Zhao, Jun, et al.
Publicado: (2015) -
Dosimetric comparison of fixed field dynamic IMRT and VMAT techniques in simultaneous integrated boost radiotherapy of prostate cancer
por: Sun, Haitao, et al.
Publicado: (2022) -
Dosimetric and radiobiological comparison of simultaneous integrated boost radiotherapy for early stage right side breast cancer between three techniques: IMRT, hybrid IMRT and hybrid VMAT
por: Bi, Suyan, et al.
Publicado: (2022) -
Dosimetric evaluation study of IMRT and VMAT techniques for prostate cancer based on different multileaf collimator designs
por: Fathy, Mohamed M., et al.
Publicado: (2022)